BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37340564)

  • 1. Chilblain-Like Lesions (CLL) Coinciding With the SARS-CoV-2 Pandemic in Children: A Systematic Review.
    Starkey SY; Kashetsky N; Lam JM; Dutz J; Mukovozov IM
    J Cutan Med Surg; 2023; 27(3):277-284. PubMed ID: 37340564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chilblain-like lesions coinciding with the SARS-CoV-2 pandemic.
    Starkey SY; Mar K; Kashetsky N; Lam JM; Dutz J; Mukovozov I
    Clin Dermatol; 2023; 41(1):223-229. PubMed ID: 36228990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chilblain-Like Lesions (CLL) Associated With COVID-19 ("COVID Toes"): A Systematic Review.
    Kashetsky N; Mukovozov IM; Bergman J
    J Cutan Med Surg; 2021; 25(6):627-633. PubMed ID: 33849305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chilblain or perniosis-like skin lesions in children during the COVID-19 pandemic: A systematic review of articles.
    Molaee H; Emadi SN; M Imunya JMN; Davoudi-Monfared E; Mohammed A; Razavi Z
    Dermatol Ther; 2022 Mar; 35(3):e15298. PubMed ID: 34981615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
    El Hachem M; Diociaiuti A; Concato C; Carsetti R; Carnevale C; Ciofi Degli Atti M; Giovannelli L; Latella E; Porzio O; Rossi S; Stracuzzi A; Zaffina S; Onetti Muda A; Zambruno G; Alaggio R
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2620-2629. PubMed ID: 32474947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major cluster of paediatric 'true' primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown.
    Neri I; Virdi A; Corsini I; Guglielmo A; Lazzarotto T; Gabrielli L; Misciali C; Patrizi A; Lanari M
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2630-2635. PubMed ID: 32533899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiopathic perniosis presenting as acral purpuric lesions: Clustering of cases before COVID-19 pandemic and their comparison with chilblain like lesions reported in the literature.
    Jindal R; Chauhan P; Goyal D; Shirazi N
    Dermatol Ther; 2021 May; 34(3):e14951. PubMed ID: 33740317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are the chilblain-like lesions observed during the COVID-19 pandemic due to severe acute respiratory syndrome coronavirus 2? Systematic review and meta-analysis.
    Sánchez-García V; Hernández-Quiles R; de-Miguel-Balsa E; Docampo-Simón A; Belinchón-Romero I; Ramos-Rincón JM
    J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):24-38. PubMed ID: 34545625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Going viral: A brief history of Chilblain-like skin lesions ("COVID toes") amidst the COVID-19 pandemic.
    Massey PR; Jones KM
    Semin Oncol; 2020 Oct; 47(5):330-334. PubMed ID: 32736881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chilblain-like lesions onset during SARS-CoV-2 infection in a COVID-19-vaccinated adolescent: case report and review of literature.
    Paparella R; Tarani L; Properzi E; Costantino F; Saburri C; Lucibello R; Richetta A; Spalice A; Leonardi L
    Ital J Pediatr; 2022 Jun; 48(1):93. PubMed ID: 35698236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Most chilblains observed during the COVID-19 outbreak occur in patients who are negative for COVID-19 on polymerase chain reaction and serology testing.
    Le Cleach L; Dousset L; Assier H; Fourati S; Barbarot S; Boulard C; Bourseau Quetier C; Cambon L; Cazanave C; Colin A; Kostrzewa E; Lesort C; Levy Roy A; Lombart F; Marco-Bonnet J; Monfort JB; Samimi M; Tardieu M; Wolkenstein P; Sbidian E; Beylot-Barry M;
    Br J Dermatol; 2020 Nov; 183(5):866-874. PubMed ID: 32628270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chilblain-like acral lesions during the COVID-19 pandemic ("COVID toes"): Histologic, immunofluorescence, and immunohistochemical study of 17 cases.
    Kanitakis J; Lesort C; Danset M; Jullien D
    J Am Acad Dermatol; 2020 Sep; 83(3):870-875. PubMed ID: 32502585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic.
    Discepolo V; Catzola A; Pierri L; Mascolo M; Della Casa F; Vastarella M; Smith G; Travaglino A; Punziano A; Nappa P; Staibano S; Bruzzese E; Fabbrocini G; Guarino A; Alessio M
    JAMA Netw Open; 2021 Jun; 4(6):e2111369. PubMed ID: 34110396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID 19-associated chilblain-like acral lesions among children and adolescents: an Italian retrospective, multicenter study.
    Romita P; Maronese CA; DE Marco A; Balestri R; Belloni Fortina A; Brazzelli V; Colonna C; DI Lernia V; El Hachem M; Fabbrocini G; Foti C; Frasin LA; Guarneri C; Guerriero C; Guida S; Locatelli A; Neri I; Occella C; Offidani A; Oranges T; Pellacani G; Stinco G; Stingeni L; Barbagallo T; Campanati A; Cannavò SP; Caroppo F; Cavalli R; Costantini A; Cucchia R; Diociaiuti A; Filippeschi C; Francomano M; Giancristoforo S; Giuffrida R; Martina E; Monzani NA; Nappa P; Pastorino C; Patrizi A; Peccerillo F; Peris K; Recalcati S; Rizzoli L; Simonetti O; Vastarella M; Virdi A; Marzano AV; Bonamonte D
    Ital J Dermatol Venerol; 2023 Apr; 158(2):117-123. PubMed ID: 37153946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic.
    Hubiche T; Cardot-Leccia N; Le Duff F; Seitz-Polski B; Giordana P; Chiaverini C; Giordanengo V; Gonfrier G; Raimondi V; Bausset O; Adjtoutah Z; Garnier M; Burel-Vandenbos F; Dadone-Montaudié B; Fassbender V; Palladini A; Courjon J; Mondain V; Contenti J; Dellamonica J; Leftheriotis G; Passeron T
    JAMA Dermatol; 2021 Feb; 157(2):202-206. PubMed ID: 33237291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chilblains in children in the setting of COVID-19 pandemic.
    Andina D; Noguera-Morel L; Bascuas-Arribas M; Gaitero-Tristán J; Alonso-Cadenas JA; Escalada-Pellitero S; Hernández-Martín Á; de la Torre-Espi M; Colmenero I; Torrelo A
    Pediatr Dermatol; 2020 May; 37(3):406-411. PubMed ID: 32386460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do we have serological evidences that chilblain-like lesions are related to SARS-CoV-2? A review of the literature.
    Balestri R; Magnano M; Rizzoli L; Rech G
    Dermatol Ther; 2020 Nov; 33(6):e14229. PubMed ID: 32844512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of pernio-like cutaneous manifestations in children during the outbreak of COVID-19.
    Gallizzi R; Sutera D; Spagnolo A; Bagnato AM; Cannavò SP; Grasso L; Guarneri C; Nunnari G; Mazza F; Pajno GB
    Dermatol Ther; 2020 Nov; 33(6):e14312. PubMed ID: 32949449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of incidence of chilblain-like lesions in children during the first year of COVID-19 pandemic.
    Bascuas-Arribas M; Andina-Martinez D; Añon-Hidalgo J; Alonso-Cadenas JA; Hernandez-Martin A; Lamagrande-Casanova N; Noguero-Morel L; Mateos-Mayo A; Colmenero-Blanco I; Torrelo A
    Pediatr Dermatol; 2022 Mar; 39(2):243-249. PubMed ID: 35129855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID toes: where do we stand with the current evidence?
    Baeck M; Herman A
    Int J Infect Dis; 2021 Jan; 102():53-55. PubMed ID: 33075530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.